Title: Value of human epididymis secretory protein 4 in the diagnosis and treatment of ovarian cancer
Abstract: Objective
To investigate the clinical value of human epididymis secretory protein 4 (HE4) in the diagnosis of ovarian cancer.
Methods
A total of 105 patients with ovarian carcinoma from July 2014 to December 2015 were selected as observation group, and another 90 cases with benign ovarian lesions were selected as control group A and 130 cases of healthy people were selected as control group B, the serum CA125 and HE4 levels of the three groups were determined, and the test result were analysiss.
Results
The serum level of HE4 in observation group were significantly higher than that in the control group, the difference was significant (P 0.05).
Conclusions
Serum HE4 is a good marker for ovarian cancer; it can contribute to effective identification of uterine benign and malignant lesions, and have very positive role in the early diagnosis of ovarian cancer, so it is recommended to be further promoted in the clinics to improve the early diagnosis of ovarian cancer.
Key words:
Ovarian cancer; Human epididymal epithelial secretory protein 4; Pathological diagnosis
Publication Year: 2017
Publication Date: 2017-02-10
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot